Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Twelve outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, including articles from three Medical Sciences DPhil students.

The Max Perutz Award, the MRC's annual writing competition, asks MRC-funded PhD students to write up to 800 words about their research and why it matters, in a way that would interest a non-scientific audience.

Congratulations to the three Medical Sciences DPhil students who have been shortlisted:

  • Magda Mareckova, Nuffield Department of Women's & Reproductive Health:“One in ten women suffers from endometriosis - can studying the endometrium cell by cell help us diagnose it?” Read more
  • Akira Wiberg, Nuffield Department of Orthopaedic, Rheumatology & Musculoskeletal Sciences: “Getting on your nerves” 
  • Amy Southern, Department of Biochemistry/MRC Harwell: “Making sense of a sticky situation: finding the 'glue ear gene' in Down syndrome". Read more

The winner, who will receive a £1,500 prize, will be announced at the awards ceremony on 15 October at the Royal Institution, London. All shortlisted articles will be published on the MRC website on 16 October.

Read more (MRC website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.